$MYRX Myrexis, Inc. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Myrexis, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in Myrexis, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

Myrexis, Inc. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Aryeh JasonDirector545,24521,810Jun 20 2012
Belle Gerald P.Director00Jul 06 2009
Belle Gerald P.Director77,2303,089May 17 2012
Berry BarbaraSVP, Human Resources15,422617Sep 14 2009
Berry BarbaraSVP, Human Resources17,284691Feb 26 2010
COUCHMAN JONATHAN10% Owner1,615,19464,608Aug 26 2020
First Eagle Investment Management, LLC10% Owner2,671,617106,865Nov 05 2012
Forrester RobertDirector00Dec 12 2011
Forrester RobertDirector00Jul 06 2009
Franson Timothy RDirector00Sep 14 2009
Franson Timothy RDirector00Dec 12 2011
Gibbs AndrewVice President, Legal9,000360Sep 14 2009
Gibbs AndrewVice President, Legal7,847314Jun 18 2010
Gibbs AndrewVP, General Counsel19,847794Sep 28 2010
HENDERSON JOHN TDirector00Jul 06 2009
HENDERSON JOHN TDirector33,5001,340Jan 25 2013
HOBDEN ADRIAN NPresident and CEO108,5174,341Sep 14 2009
HOBDEN ADRIAN NPresident and CEO162,7876,511Apr 19 2010
HOBDEN ADRIAN NPresident and CEO208,3728,335Sep 28 2010
Kendell AndreaChief Financial Officer33,0941,324Sep 27 2012
LANGER DENNISDirector00Jul 06 2009
LANGER DENNISDirector00Dec 12 2011
Laslie W WayneChief Operating Officer28,3571,134Sep 14 2009
Laslie W WayneChief Operating Officer00Feb 22 2010
Laslie W WayneChief Operating Officer57,2542,290Sep 28 2010
LOLLINI ROBERT JChief Financial Officer21,000840Sep 14 2009
LOLLINI ROBERT JChief Financial Officer00Feb 22 2010
LOLLINI ROBERT JPresident and CEO44,6901,788Sep 26 2011
MYRIAD GENETICS INC10% Owner00Jun 19 2009
Swabb EdwardSVP, Drug Development, CMO15,000600Sep 14 2009
Swabb EdwardSVP, Drug Development, CMO00Feb 22 2010